Chinese warning on Hinkley
Hinkley Point is the world's most expensive nuclear project. After intervention from the Chinese ambassador, it is also now the litmus test for Anglo-China relations under the new regime at Number 10. After EDF's board narrowly agreed to press ahead with the project, the UK government surprised company officials by saying it needed several weeks to consider before signing. The decision to delay is widely thought to have come from Theresa May herself, influenced by Joint Chief of Staff and o..>> view originalTwilio beats expectations with revenue of $64.5M in solid Q2 earnings
Twilio, exceeded revenue expectations in Q2 earnings released today after the bell. Immediately share prices increased in after-hours trading before falling back to the market closing price. The cloud-communications company reported revenue of $64.5 million and a loss per share of $0.08. Twilio beat revenue by over 10 percent. Analysts had expected a loss of $0.14 per share on revenue of $58.22 million. Twilio stock was priced at $15 back in June for its IPO. Over the last two months, the comp..>> view originalAfter outage, Delta offers refunds, vouchers
David Koenig, Associated Press 7:05 a.m. EDT August 9, 2016Like this topic? You may also like these photo galleries:AutoplayShow ThumbnailsShow CaptionsLast SlideNext SlidePassengers line up at check-in counter for Delta Air Lines at Narita international airport in Narita, east of Tokyo, Tuesday, Aug. 9, 2016.(Photo: Shizuo Kambayashi, AP)DALLAS - Delta Air Lines will be handing out refunds and travel vouchers as penance for the latest computer outage to knock a major airline off st..>> view originalAnalysts stunned by 115% premium in Mattress Firm takeover bid
News that a family-owned South African company has agreed to acquire the biggest specialty mattress retailer in the U.S. shocked some analysts with the deal’s size and cost. Steinhoff International Holdings NV SNH, -0.10% ..>> view originalVeteran Job Site Monster Finally Found a Buyer
The Dutch recruitment agency Randstad has continued its acquisition drive in the digital world by buying one of the big names of the dotcom era, Monster. The deal is worth around $429 million, representing a per-share price of $3.40. Monster Worldwide mww , which runs the heavily trafficked Monster.com service and was making acquisitions of its own as recently as two months ago, will continue to operate as an independent entity under its own name. “With its industry leading technology pla..>> view original50 GOP national security experts oppose Trump
The letter, first reported by The New York Times Monday, warns: "We are convinced that in the Oval Office, he would be the most reckless President in American history." Its signatories include former CIA and National Security Agency Director Michael Hayden, former Director of National Intelligence and Deputy Secretary of State John Negroponte and Eric Edelman, who was Vice President Dick Cheney's national security adviser and has worked closely with Michele Flournoy -- a candidate for secretary ..>> view originalThe Oddities In Barclay's $100 Million Libor Settlement In The US
Solid Outlook From Valeant, Promised Changes, Fire Up Shares
NEW YORK — Valeant Pharmaceuticals reported a wider loss and a dip in revenue during the second quarter, but shares jumped Tuesday after the beleaguered company stuck by its outlook and said it was undergoing a restructuring to return itself to normalcy.Valeant is dealing with three federal probes into its accounting and business practices and insurers who want relief from higher drug prices put into place for reasons now under scrutiny. The company has come under a harsh spotlight after buyin..>> view originalPharming Announces Acquisition of all North American Commercialisation Rights to RUCONEST From Valeant
LEIDEN, The Netherlands, Aug 09, 2016 (PR Newswire Europe via COMTEX) -- LEIDEN, The Netherlands, August 9, 2016 /PRNewswire/ -- Pharming Group N.V. (the "Company") announces today that it has entered into a definitive agreement to acquire all North American commercialisation rights to its own product RUCONEST(R) (recombinant human C1 esterase inhibitor), including all rights in the US, Mexico and Canada, from Valeant Pharmaceuticals International, Inc. ("Valeant") . RUCONEST(R) is an orphan d..>> view originalBrexit will affect Canada's trade with Britain, but how?
X To continue reading this article, you must be a Globe Unlimited subscriber. Don't stop here. Go unlimited. A Globe Unlimited subscription also gives you: Full access to all our award-winning news articles and exclusive features Access and availability on all devices and platforms Real-time Stock Quotes that remove the 15-minute stock price delay on all Canadian stock portals Reuters Financial News providing key insights from the world's best economies and markets newsroom Subscribe ..>> view original
Tuesday, August 9, 2016
Chinese warning on Hinkley and other top stories.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment